FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893025311> ?p ?o ?g. }

• W2893025311 endingPage "11" @default.
• W2893025311 startingPage "1" @default.
• W2893025311 abstract "Nonalcoholic fatty liver disease (NAFLD) is a metabolic-related disorder ranging from steatosis to steatohepatitis, which may progress to cirrhosis and hepatocellular carcinoma (HCC). This study aimed at assessing the regulatory and protective role of miR-26a on lipid metabolism and progression of NAFLD in human HepG2 cells loaded with free fatty acids (FFA). Lentivirus expressing miR-26a or negative control miR was used to transduce HepG2 cells and to establish stable cell lines. Gain or loss of function using an miR-26a inhibitor was used to compare triglyceride content (TG), total cholesterol level (CL), total antioxidant capacity (TAC), malondialdehyde (MDA) and the level of apoptosis. In addition, quantitative reverse transcription polymerase chain reaction (qPCR) was used to assess the mRNA levels of lipogenesis, TG synthesis, storage genes, inflammatory and fibrogenic markers, and autophagic besides endoplasmic reticulum (ER) stress markers after gaining or losing the function of miR-26a. miR-26a levels decreased in response to FFA in human HepG2 cells. After the establishment of a stable cell line, the upregulation of miR-26a resulted in the downregulation of TG, CL, and MDA levels, through regulating mRNA levels of genes involved in lipid homeostasis, ER stress marker, inflammatory and fibrogenic markers. Nevertheless, there was a marked increment in the mRNA expression of autophagic marker genes. Moreover, miR-26a overexpression protects the cells from apoptosis, whereas inhibition of miR-26a, using an anti-miR-26a oligonucleotide, decreased the expression of miR-26a which potentially contributes to altered lipid metabolism in HepG2 cells loaded with FFA. In conclusion, these findings suggested that miR-26a has a crucial role in regulating fatty acid and cholesterol homeostasis in HepG2 cells, along with the offered protection against the progression of NAFLD in vitro . Hence, miRNAs could receive growing attention as useful noninvasive diagnostic markers to follow the progression of NAFLD and to identify novel therapeutic targets." @default.
• W2893025311 created "2018-10-05" @default.
• W2893025311 creator A5029054950 @default.
• W2893025311 creator A5054371652 @default.
• W2893025311 creator A5071329096 @default.
• W2893025311 creator A5089708941 @default.
• W2893025311 date "2018-09-30" @default.
• W2893025311 modified "2023-10-10" @default.
• W2893025311 title "miR-26a Potentially Contributes to the Regulation of Fatty Acid and Sterol Metabolism In Vitro Human HepG2 Cell Model of Nonalcoholic Fatty Liver Disease" @default.
• W2893025311 cites W14098964 @default.
• W2893025311 cites W1440460151 @default.
• W2893025311 cites W1485267747 @default.
• W2893025311 cites W1489213426 @default.
• W2893025311 cites W1545307027 @default.
• W2893025311 cites W1967686561 @default.
• W2893025311 cites W1967972402 @default.
• W2893025311 cites W1968872717 @default.
• W2893025311 cites W1969734540 @default.
• W2893025311 cites W1983524067 @default.
• W2893025311 cites W1985333297 @default.
• W2893025311 cites W1988473628 @default.
• W2893025311 cites W1993458861 @default.
• W2893025311 cites W1997901667 @default.
• W2893025311 cites W2002724169 @default.
• W2893025311 cites W2002995168 @default.
• W2893025311 cites W2007505836 @default.
• W2893025311 cites W2013570209 @default.
• W2893025311 cites W2013577132 @default.
• W2893025311 cites W2014630029 @default.
• W2893025311 cites W2019185659 @default.
• W2893025311 cites W2020034534 @default.
• W2893025311 cites W2020823261 @default.
• W2893025311 cites W2022005070 @default.
• W2893025311 cites W2023195072 @default.
• W2893025311 cites W2034209605 @default.
• W2893025311 cites W2034298464 @default.
• W2893025311 cites W2034889452 @default.
• W2893025311 cites W2039636142 @default.
• W2893025311 cites W2039874361 @default.
• W2893025311 cites W2040109162 @default.
• W2893025311 cites W2040615010 @default.
• W2893025311 cites W2042559265 @default.
• W2893025311 cites W2043044337 @default.
• W2893025311 cites W2044993806 @default.
• W2893025311 cites W2047493201 @default.
• W2893025311 cites W2052719041 @default.
• W2893025311 cites W2066151486 @default.
• W2893025311 cites W2080901528 @default.
• W2893025311 cites W2090480356 @default.
• W2893025311 cites W2092393877 @default.
• W2893025311 cites W2092412521 @default.
• W2893025311 cites W2096364245 @default.
• W2893025311 cites W2097982673 @default.
• W2893025311 cites W2116393673 @default.
• W2893025311 cites W2118338384 @default.
• W2893025311 cites W2128015661 @default.
• W2893025311 cites W2136382192 @default.
• W2893025311 cites W2136573376 @default.
• W2893025311 cites W2139568257 @default.
• W2893025311 cites W2144275312 @default.
• W2893025311 cites W2163443770 @default.
• W2893025311 cites W2254967598 @default.
• W2893025311 cites W2460114700 @default.
• W2893025311 cites W2525184662 @default.
• W2893025311 cites W2597632520 @default.
• W2893025311 cites W2809915044 @default.
• W2893025311 doi "https://doi.org/10.1155/2018/8515343" @default.
• W2893025311 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6196797" @default.
• W2893025311 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30402207" @default.
• W2893025311 hasPublicationYear "2018" @default.
• W2893025311 type Work @default.
• W2893025311 sameAs 2893025311 @default.
• W2893025311 citedByCount "33" @default.
• W2893025311 countsByYear W28930253112019 @default.
• W2893025311 countsByYear W28930253112020 @default.
• W2893025311 countsByYear W28930253112021 @default.
• W2893025311 countsByYear W28930253112022 @default.
• W2893025311 countsByYear W28930253112023 @default.
• W2893025311 crossrefType "journal-article" @default.
• W2893025311 hasAuthorship W2893025311A5029054950 @default.
• W2893025311 hasAuthorship W2893025311A5054371652 @default.
• W2893025311 hasAuthorship W2893025311A5071329096 @default.
• W2893025311 hasAuthorship W2893025311A5089708941 @default.
• W2893025311 hasBestOaLocation W28930253111 @default.
• W2893025311 hasConcept C104317684 @default.
• W2893025311 hasConcept C126322002 @default.
• W2893025311 hasConcept C127561419 @default.
• W2893025311 hasConcept C134018914 @default.
• W2893025311 hasConcept C139447449 @default.
• W2893025311 hasConcept C141359234 @default.
• W2893025311 hasConcept C158617107 @default.
• W2893025311 hasConcept C185592680 @default.
• W2893025311 hasConcept C2776175330 @default.
• W2893025311 hasConcept C2776954865 @default.
• W2893025311 hasConcept C2777391703 @default.
• W2893025311 hasConcept C2778772119 @default.
• W2893025311 hasConcept C2779134260 @default.
• W2893025311 hasConcept C2779478299 @default.

• next